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ABSTRACT
The ATP analog ATPγS inhibits pre-mRNA splicing in vitro, but there have been conflicting reports as to which step of splicing is
inhibited by this small molecule and its inhibitory mechanism remains unclear. Here we have dissected the effect of ATPγS on
pre-mRNA splicing in vitro. Addition of ATPγS to splicing extracts depleted of ATP inhibited both catalytic steps of splicing. At
ATPγS concentrations ≥0.5 mM, precatalytic B complexes accumulate, demonstrating a block prior to or during the spliceosome
activation stage. Affinity purification of the ATPγS-stalled B complexes (BATPγS) and subsequent characterization of their
abundant protein components by 2D gel electrophoresis revealed that BATPγS complexes are compositionally more homogeneous
than B complexes previously isolated in the presence of ATP. In particular, they contain little or no Prp19/CDC5L complex
proteins, indicating that these proteins are recruited after assembly of the precatalytic spliceosome. Under the electron
microscope, BATPγS complexes exhibit a morphology highly similar to B complexes, indicating that the ATPγS-induced block in
the transformation of the B to Bact complex is not due to a major structural defect. Likely mechanisms whereby ATPγS blocks
spliceosome assembly at the activation stage, including inhibition of the RNA helicase Brr2, are discussed. Given their more
homogeneous composition, B complexes stalled by ATPγS may prove highly useful for both functional and structural analyses of
the precatalytic spliceosome and its conversion into an activated Bact spliceosomal complex.
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INTRODUCTION
Pre-mRNA splicing is catalyzed by the spliceosome, a dy-
namic highly complex RNPmachine. Assembly of the splice-
osome occurs by the stepwise interaction of the U1, U2, U4/
U6, and U5 snRNPs, plus many additional non-snRNP pro-
teins with the pre-mRNA (for review, see Wahl et al. 2009;
Will and Lührmann 2011). The spliceosome carries out
two successive transesterification reactions that lead to re-
moval of an intron and the ligation of its flanking exons.
Spliceosome assembly initiates by the ATP-independent as-
sociation of U1 with the 5′ splice site (ss) and initial docking
of the U2 snRNP, forming the spliceosomal E complex
(Michaud and Reed 1991). Stable integration of the U2
snRNP via its interaction with the branch site (BS) of the
pre-mRNA’s intron, generates the A complex. The recruit-
ment and stable integration of the U4/U6.U5 tri-snRNP to
the spliceosome follows, yielding the precatalytic B complex
which does not yet have an active center. During the subse-
quent catalytic activation of the spliceosome, which generates
the Bact complex, the extensively base paired U4/U6 snRNAs
are unwound, thereby releasing U4 and allowing the forma-
tion of newU2/U6 base-pairing interactions and a catalytical-
ly important U6 internal stem–loop (ISL) (Valadkhan 2013).
Concomitant with or prior to this, the base-pairing interac-
tion between the pre-mRNA’s 5′ss and the U1 snRNA must
be disrupted, in order to allow base-pairing between U6’s
highly conserved ACAGA sequence and the 5′ end of the in-
tron (Staley and Guthrie 1998). This newly formed U2–U6-
pre-mRNA RNA interaction network comprises the catalytic
centre of the spliceosome (Valadkhan 2013). After additional
RNP rearrangements, the catalytically active B∗ complex
forms and catalyzes the first transesterification reaction of
splicing. This involves cleavage at the 5′ss and ligation of
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the 5′ end of the intron to the branch site, and generates the
splicing intermediates, the excised 5′ exon and the lariat-
shaped intron-3′exon. The subsequently formed C complex
then catalyzes the second transesterification reaction of splic-
ing, involving excision of the intron and ligation of the 5′ and
3′ exon to form the mRNA.
Over 170 proteins are associated at one time or another
with the human splicing machinery and there is a dramatic
exchange of proteins during the transitions from one spliceo-
somal complex to the next (Wahl et al. 2009; Wahl and
Lührmann 2015). Our knowledge about the spliceosome’s
highly complex compositional dynamics is, however, ham-
pered by the limited number of distinct spliceosomal com-
plexes that can be biochemically detected or isolated. Given
the extensive exchange of proteins during the transitions
from the B to Bact, and Bact to C complex, there are likely
to be numerous additional, intermediate assembly stages in
which only a subset of these proteins are released or recruit-
ed. Currently, many preparations of purified human spliceo-
somal complexes likely consist of a mixture of assembly
stages, which prevents a clear picture of when some spliceo-
somal proteins are first recruited during assembly. To over-
come this problem, small molecule inhibitors of splicing
have more recently been used with the hope of obtaining
more homogeneous populations of splicing complexes by
stalling splicing at a highly specific stage (Kuhn et al. 2009;
Berg et al. 2012; Effenberger et al. 2013, 2015; Pawallek
et al. 2015).
ATP is required for each step of spliceosome assembly/
disassembly and the catalytic steps of splicing, except for
the association of U1 and U2 during the earliest stage of
spliceosome assembly (i.e., E complex formation). However,
the transesterification reactions per se do not consume ATP.
At least eight conserved ATP-dependent DExD/H-box
RNA/RNP remodeling enzymes drive themultiple rearrange-
ments of the spliceosome during its working cycle and
account for the ATP dependence of most structural rear-
rangements (Cordin and Beggs 2013; Liu and Cheng 2015).
The DEAD-box helicases Sub2 and Prp5 are required for sta-
ble U2 snRNP integration during A complex assembly. Dur-
ing B complex formation, the DEAD-box protein Prp28
catalyzes the exchange of U1 with U6 at the 5′ss (Staley and
Guthrie 1999), and during the transition from complex B
to Bact, the DExD/H-box protein Brr2 of the Ski-2 helicase
family catalyzes a key step in spliceosome activation, namely
the unwinding of U4/U6 snRNA (Laggerbauer et al. 1998;
Raghunathan and Guthrie 1998). The DExH/D-box protein
Prp2 promotes an RNP remodeling event that converts Bact
into the catalytically active B∗ complex (Kim and Lin 1996;
Warkocki et al. 2009; Lardelli et al. 2010). The remaining
DExD/H-box proteins Prp16, Prp22 and Prp43 promote
conformational rearrangements during the catalytic steps
of splicing and/or are involved in spliceosome disassembly
(for review, see Cordin and Beggs 2013; Liu and Cheng
2015).
ATP is required not only for the ATPases/RNA helicases
that drive the conformational rearrangements in the spliceo-
some, but also for the many kinases and phosphatases
involved in the phosphorylation/dephosphorylation of nu-
merous spliceosomal proteins. For example, SR protein
phosphorylation/dephosphorylation is essential for pre-
mRNA splicing (for review, see Misteli 1999; Soret and
Tazi 2003), with SR protein phosphorylation shown to be re-
quired during spliceosome assembly (Mermoud et al. 1994;
Xiao andManley 1997). Dephosphorylation of several splice-
osomal phosphoproteins is required for the catalytic steps of
splicing, with PP1/PP2A phosphatases playing key roles at
this stage (Mermoud et al. 1992; Shi et al. 2006).
The small molecule ATP analog ATPγS has been used to
study the requirement for protein dephosphorylation during
splicing, as thiophosphorylated proteins are poorly dephos-
phorylated by protein phosphatases (Li et al. 1988). Kinases
can use ATPγS to thiophosphorylate proteins, making
them resistant to rapid dephosphorylation. ATPγS can be hy-
drolyzed by some enzymes but usually at a much lower rate
compared with ATP (Yount 1975). Addition of ATPγS to
in vitro splicing reactions was initially reported to stall splic-
ing during the second catalytic step (Tazi et al. 1992). In con-
trast, subsequent studies indicated that thiophosphorylation
of the U1-70K protein (Tazi et al. 1993) or SR proteins
(Cao et al. 1997), which were added back to nuclear or
S100 extract lacking these proteins, blocked splicing prior
to the first step of splicing, but after the B complex stage.
However, the precise stage at which spliceosome assembly
is blocked was not clear.
Here we have analyzed the effect of ATPγS on splicing in
vitro, and characterized the composition and structure of
splicing complexes that accumulate in the presence of
ATPγS. Our studies indicate that ATPγS blocks splicing
just prior to the action of Brr2, at a stage after B complex for-
mation but prior to U4/U6 unwinding during spliceosome
activation. In contrast to previous preparations of the human
B complex, which consist of a mixture of assembly states due
to the fact that they are kinetically stalled, B complexes that
accumulate in the presence of ATPγS are essentially devoid
of Prp19/CDC5L complex proteins and thus more homoge-
neous. Thus, our data indicate that highly pure B complexes
lack the latter proteins and therefore that the hPrp19/CDC5
proteins first interact during Bact formation, after/concomi-
tant with dissociation of U4. Taken together, our data also re-
veal that ATPγS can be used as an efficient small molecule
inhibitor of splicing to generate spliceosomal complexes
stalled at a very specific stage of the assembly process.
RESULTS AND DISCUSSION
To elucidate its effect on pre-mRNA splicing in vitro, we add-
ed increasing amounts of ATPγS to a splicing reaction con-
taining HeLa nuclear extract and 32P-labeled MINX pre-
mRNA with MS2 aptamers for affinity purification (Fig. 1).
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The extract was first depleted of ATP by preincubating with 2
mM glucose for 30 min at 30°C (Michaud and Reed 1991),
which abolished both steps of splicing (Fig. 1A, compare
lanes 16–18 with 19–21 where ATP/creatine phosphate, CP,
were subsequently added), and inhibited splicing complex
formation (Fig. 1B). Both catalytic steps of splicing were
completely inhibited at all concentrations of ATPγS tested
(0.25–4.0 mM), even after incubating for 3 h (Fig. 1A) or 6
h (data not shown). Addition of low concentrations (0.25–
1.0 mM) of ATPγS led to an accumulation of A complexes,
whereas at higher concentrations spliceosomal complexes
migrating like a B complex accumulated (Fig. 1B). The accu-
mulation of B complexes was specific for ATPγS, as the addi-
tion of the nonhydrolyzable AMP-PNP, which also inhibited
splicing completely, abolished both A and B complex forma-
tion at 2 mM (Fig. 1C, lanes 10–12 and Fig. 1D, lanes 16–20).
These results suggest that the accumulation of precatalytic
splicing complexes in the presence of ATPγS results either
from the thiophosphorylation of one or more spliceosomal
proteins or the inhibition of one or more ATP-dependent en-
zymes involved in the splicing process. Previous studies indi-
cated that ATPγS blocks in vitro splicing first during the
catalytic steps of splicing (Tazi et al. 1992). However, the
splicing reactions performed by Tazi and colleagues con-
tained creatine phosphate (CP) in addition to ATPγS; thus
most of the hydrolyzed ATP analog could be regenerated to
ATP, which could explain why their splicing reactions were
not blocked at an earlier stage similar to ours. Indeed, thio-
phosphorylation of U1-70K, which would occur under our
conditions, was shown to block splicing prior to step 1 but
FIGURE 1. ATPγS blocks spliceosome assembly before catalytic activation. (A) In vitro splicing of 32P-labeled MINX pre-mRNAwas performed for
the indicated times in untreated HeLa nuclear extract (lanes 22–24) or extract depleted of ATP by incubating with 2 mM glucose (lanes 1–21). Splicing
was carried out in the presence of 2 mM ATP and creatine phosphate ATP/CP (lanes 19–24) or in the presence of increasing concentrations of ATPγS
(in the absence of ATP) as indicated above (lanes 1–18). Splicing was analyzed by denaturing PAGE and the positions of the pre-mRNA substrate and
intermediates/products of the splicing reaction are shown on the right. The spliced out lariat has been debranched and thus is not visible above the
unspliced pre-mRNA. (B) In vitro splicing was performed as in A, and the formation of splicing complexes was analyzed on a native agarose gel. The
positions of the splicing complexes (A, B, Bact, and C), as well as the H complex, are indicated on the left. (C) In vitro splicing as in A, performed in
ATP-depleted extract (lanes 1–3) or ATP-depleted extract supplemented with 2 mM ATP and CP (lanes 4–6), 2 mM ATPγS (lanes 7–9), or 2 mM
AMP-PNP (lanes 10–12) for 0–180min as indicated above. (D) Analysis of splicing complex formation (as in B) in the absence of ATP (lanes 1–5) or in
its presence (ATP/CP, lanes 6–10) or in the presence of 2 mMATPγS (lanes 11–15) or AMP-PNP (lanes 16–20). Splicing was performed for 0–60 min
as indicated above each lane.
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after assembly of the spliceosome (Tazi et al. 1993), consis-
tent with ATPγS affecting splicing before the catalytic steps.
Affinity purification of A complexes stalled
with ATPγS
To characterize the spliceosomal complexes stalled by ATPγS
in more detail we affinity purified them byMS2 affinity selec-
tion. Complexes were assembled in splicing extract depleted
of ATP and supplemented with 0.4 mM (for isolation of A
complexes) or 2 mM ATPγS for the isolation of stalled B
complexes. Splicing complexes were purified from the splic-
ing reaction by MS2 affinity selection and then subjected to
glycerol gradient centrifugation.
Two main peaks were observed in the presence of 0.4 mM
ATPγS (Fig. 2A). The faster migrating peak contained com-
plexes with equimolar amounts of the MINX pre-mRNA
and U1 and U2 snRNPs as evidenced by their RNA compo-
sition (Fig. 2B), indicating that they are spliceosomal A com-
plexes. Proteins of these affinity-purified complexes were
FIGURE 2. Affinity purification of A complexes accumulating in the presence of ATPγS. (A) Splicing complexes were allowed to form on 32P-MINX
pre-mRNA containingMS2 aptamers bound byMS2-MBP protein, in HeLa nuclear extract containing 0.4 mMATPγS. Complexes were subsequently
affinity purified on an amylose column and the eluate subjected to glycerol gradient centrifugation in buffer containing 150 mMNaCl. The number of
cpm in each gradient fraction is plotted. (B) RNA composition of complexes in the faster migrating peak (fraction #13). (C) Proteins from affinity-
purified A complexes formed in the presence of ATPγS (fractions #13–14) were separated by 2D gel electrophoresis, stained with RuBPS, and the
identities of protein spots were determined by mass spectrometry. Proteins smaller than 25 kDa were not analyzed. Abundant proteins are indicated
in black and less abundant ones in gray. (D) Summary of abundant/moderately abundant proteins identified in AATPγS complexes.
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subsequently analyzed by 2D gel electrophoresis followed by
mass spectrometry (MS) to identify abundant components
(Fig. 2C,D). Abundant or moderately abundant proteins
(with a molecular mass above 25 kDa) in the A complexes
stalled by ATPγS (henceforth denoted AATPγS) included: (i)
all 12S U1 and 17S U2 proteins, (ii) the 17S U2-related pro-
teins U2AF65, U2AF35, and PUF60, which bind the polypyr-
imidine tract, (iii) the SR proteins SRSF1 and SRSF7, (iv)
ASR2B and finally S164/RBM25 (RNA-bindingmotif protein
25), which was shown to regulate the alternative splicing of
the apoptotic factor Bcl-x pre-mRNA by promoting the re-
cruitment of U1 snRNP to a weak 5′ss (Zhou et al. 2008).
A highly similar set of abundant proteins was detected in af-
finity-purified A complexes formed in the presence of ATP
(Agafonov et al. 2011). Thus, complexes with a protein com-
position generally characteristic for the A complex can be as-
sembled with ATPγS as the sole energy source and these
AATPγS complexes support efficient B complex formation if
the concentration of ATPγS is above ∼0.25 mM (Fig. 1B).
Phosphorylation of SR proteins is required for spliceosome
assembly (Zhou and Fu 2013), and these results indicate that
thio-phosphorylated SR (and other proteins) are still func-
tional at this stage, consistent with previous observations
(Tazi et al. 1993; Cao et al. 1997). Our results also indicate
that low concentrations of ATPγS are sufficient for Prp5
and Sub2 activity at this stage of spliceosome assembly, con-
sistent with a requirement for ATP binding, rather than ATP
hydrolysis (or at least rapid hydrolysis) for their function in
splicing. Indeed, DEAD-box proteins often can act after
binding ATP (even without hydrolyzing it), which leads to
a conformational change in the DEAD-box protein that
can alter the local structure of bound RNA/RNPs (Cordin
and Beggs 2013).
Characterization of B complexes formed
in the presence of ATPγS
After MS2 affinity selection and subsequent glycerol gradient
centrifugation, two peaks with S-values of ∼40S and ∼60S
were consistently observed at an ATPγS concentration of 2
mM (Fig. 3A), where predominantly B complexes were ob-
served on native agarose gels (Fig. 1B). The RNA composi-
tion of fractions comprising each peak was subsequently
analyzed and revealed an identical snRNA composition.
That is, complexes peaking in both regions of the gradient
contained equimolar amounts of U2, U4, U5, U6, and
MINX RNA, but almost no U1 snRNA, similar to affinity-pu-
rified B complexes generated by incubating the splicing reac-
tion for 5–7 min (Agafonov et al. 2011). Analysis of the
protein composition of the 40S and 60S complexes revealed
a very similar protein composition (data not shown); thus,
the faster migrating peak likely contains dimers of the B com-
plexes that accumulate in the presence of ATPγS.
Abundant proteins present in the monomeric B complexes
stalled in the presence of ATPγS (denoted BATPγS) were
determined by 2D gel electrophoresis followed by mass spec-
trometry (MS) (Fig. 3C,D). Abundant or moderately abun-
dant proteins (with a molecular mass above 25 kDa) in the
BATPγS complexes included: (i) nearly all 17S U2, U5, and
U4/U6 snRNP proteins, (ii) the tri-snRNP-specific proteins
Snu66/110K and Sad1/65K, (iii) the so-called B-specific pro-
teins hSmu1, MFAP1, RED, hSnu23, hPrp38, and FBP21,
(iv) the Prp19 complex related proteins NPW38 and
NPW38BP, (v) the 17S U2-related proteins U2AF65,
U2AF35 and, as well as the DEXH-box protein Prp43, and
(vi) the SR proteins SRSF1 and SRSF7. A very similar set of
abundant proteins was previously reported for B complexes
formed in the presence of ATP (Agafonov et al. 2011).
However, unlike kinetically stalled B complexes, BATPγS
complexes contained little or no proteins of the Prp19/
CDC5L complex or Prp19-related proteins; only a low level
of the Prp19 protein that is normally present in four copies
in the Bact spliceosome was detected by 2D gel electrophoresis
(Fig. 3C). Thus, BATPγS complexes appear to have a much
more homogeneous protein composition than previously re-
ported B complexes. Indeed, kinetically stalled B complexes
(i.e., isolated after incubating for a defined period of time)
most certainly contain a mixture of different assembly states
of the spliceosome, leading to both compositional and struc-
tural heterogeneity. The near absence of Prp19/CDC5L pro-
teins suggests that the vast majority of BATPγS complexes are
stalled at a single assembly stage (i.e., prior to the docking/
stable integration of the Prp19/CDC5L complex proteins)
and/or that the presence of thiophosphorylated spliceosomal
proteins potentially inhibits the incorporation of Prp19/
CDC5L complex proteins. In addition, our data indicate
that the Prp19/CDC5L complex proteins are not required
for the formation of B complexes that withstand gel electro-
phoresis in the presence of heparin (Fig. 1B) (i.e., highly
stable B complexes), consistent with data showing the forma-
tion of heparin-resistant B complexes in extracts depleted of
the Prp19/CDC5L complex (Makarova et al. 2004). Although
proteins of the hPrp19/CDC5 complex are present in kinet-
ically stalled B complexes, they are first enriched and stably
associated in the spliceosomal Bact complex (Bessonov et al.
2010). Our data indicate that highly pure B complexes in
fact do not contain these proteins and that the hPrp19/
CDC5 proteins first interact during Bact formation, after/con-
comitant with dissociation of U4.
Structural characterization of the BATPγS complex by EM
To determine whether ATPγS affects the structure of the B
complexes that accumulate in its presence, we performed
negative-stain electron microscopy (EM). Well-defined, sin-
gle particles of similar shape and size were visible in the EM
overview of the monomeric BATPγS complexes (Fig. 4A).
Classification and class averaging of more than 10,000 single
particle images revealed a triangular body comprised of a
stump, a central mass and a foot, and an upper (head)
ATPγS inhibits activation of the spliceosome
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domain, which are connected via a slimmer neck domain
(Fig. 4B,D). The overall structure of the BATPγS complexes
is indistinguishable fromB complexes formed in the presence
of ATP (Fig. 4C). Like wild-type, affinity-purified B complex-
es, almost identical views are seen in all class averages,
indicating that the BATPγS complexes bind in a highly prefer-
ential orientation to the carbon film. Taken together these
data indicate that the presence of ATPγS has little or no effect
on the structural organization of the B complex. Thus, the
ATPγS-induced block in the transformation of the B to Bact
complex, leading to accumulation of B complexes, does not
appear to be due to a major structural defect.
Our data indicate that B complex formation is not hin-
dered if ATPγS is the sole source of energy in the in vitro
splicing reaction, and is present at sufficient concentrations
(i.e., >0.25mM). The requirement for a higher concentration
of ATPγS for B versus A complex formation may reflect the
different ATPγ affinities of those enzymes required at each
of these spliceosome assembly stages. The conversion of an
A to B complex requires the action of the DEAD-box helicase
Prp28, which exchanges U1 for U6 at the 5′ss (Staley and
Guthrie 1999; Mathew et al. 2008). Phosphorylation of
hPrp28 by the kinase SRPK2 also is required for B complex
formation (Mathew et al. 2008). The tri-snRNP associated
FIGURE 3. Affinity purification of B complexes accumulating in the presence of ATPγS. (A) Splicing complexes were allowed to form on 32P-MINX
pre-mRNA containingMS2 aptamers bound byMS2-MBP protein, in HeLa nuclear extract containing 2.0 mMATPγS. Complexes were subsequently
affinity purified on an amylose column and the eluate subjected to glycerol gradient centrifugation. (B) RNA composition of complexes migrating in
the 60S and 40S peaks. (C) Proteins from ATPγS stalled complexes in the 40S gradient peak were separated by 2D gel electrophoresis, stained with
Coomassie G-250, and the identities of protein spots were determined by mass spectrometry. (D) Summary of abundant/moderately abundant pro-
teins present in monomeric BATPγS complexes.
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factors hPrp31 and hPrp6 are phosphorylated by hPrp4 ki-
nase at this stage and these post-translational modifications
were also proposed to potentially contribute to stable tri-
snRNP association during B complex formation (Schneider
et al. 2010). Thus, one or more of these enzymes may require
ATPγS concentrations above 0.25 mM to allow efficient B
complex formation.
Like the DEAD-box proteins Sub2 and hPrp5, hPrp28 may
not require rapid ATP hydrolysis for its function during
splicing. However, in the presence of an ATPase deficient
hPrp28 mutant, 37S human pre-B complexes accumulate
(Boesler et al. 2016). The latter contain the U4/U6.U5 tri-
snRNP, in addition to U1 and U2, but in contrast to B com-
plexes, the tri-snRNP is not stably associated. Our data indi-
cate, however, that the block in spliceosome assembly at low
ATPγS concentrations occurs prior to the pre-B complex
stage, as the vast majority of complexes that accumulate do
not contain the tri-snRNP (Fig. 2). Thus, the block during
the A to B complex transition must occur prior to the initial
recruitment of the tri-snRNP.
As BATPγS complexes contain stoichiometric amounts of
U4 snRNA (Fig. 3), ATPγS clearly blocks the transition
from a B complex to a Bact complex during the activation
stage, which is initiated by loss/destabilization of the U4
snRNA due to Brr2-mediated unwinding of the U4/U6
duplex present in the B complex. Our purified BATPγS com-
plexes were also nearly devoid of the U1 snRNA (Fig. 3), sug-
gesting that Prp28 has already facilitated the displacement of
U1 from the 5′ss, leading to the base-pairing interaction be-
tween the U6 snRNA ACAGA box and intron nucleotides
near the 5′ss. Thus, the action of these two spliceosomal hel-
icases can apparently be uncoupled. The B complexes formed
in the presence of ATPγS do not appear to be composition-
ally or structurally compromised. Thus, ATPγS most likely
acts by inhibiting an enzyme required during the earliest stag-
es of activation, most probably the ATP-dependent DEIH
box RNA helicase Brr2. Indeed, previous studies have shown
that Brr2 cannot use ATPγS for unwinding a U4/U6 duplex
in vitro (Laggerbauer et al. 1998; Raghunathan and Guthrie
1998).
Small molecule inhibitors of splicing have proven to be
valuable tools to study spliceosome assembly and function.
To generate high-resolution structures of compositionally
and conformationally dynamic, large (several MDa) ensem-
bles such as the spliceosome, a major challenge is to obtain
complexes that are biochemically and conformationally ho-
mogeneous. Our data show that ATPγS is an important
tool to obtain more homogeneous B complexes, which are
nearly devoid of Prp19 complex and Prp19-related proteins.
This contrasts with those B complexes stalled by other small
molecule inhibitors, such as SAHA and DHC (Kuhn et al.
2009). BATPγS complexes thus may prove highly useful for
both functional and structural analyses of the precatalytic
spliceosome, as well as its conversion into an activated Bact
spliceosomal complex.
MATERIALS AND METHODS
In vitro splicing and analysis of splicing complex
formation
Uniformly [32P]-labeled, m7G(5′)ppp(5′)G-capped MINX pre-
mRNA was synthesized in vitro by T7 runoff transcription and gel
purified. HeLa nuclear extract was prepared essentially as previously
described (Dignam et al. 1983). Nuclear extract was depleted of ATP
by incubating in the presence of 2 mM glucose for 30 min at 30°C
(Michaud and Reed 1991). A typical splicing reaction contained 10
nMof 32P-labeled pre-mRNA and 40%HeLa nuclear extract in buff-
er containing 3 mM MgCl2, 65 mM KCl, 20 mM HEPES-KOH pH
7.9, 2 mM ATP, and 20 mM creatine phosphate and was incubated
at 30°C for the times indicated. Alternatively, instead of adding
ATP and creatine phosphate, the reactions were supplemented
with 0.25 to 4 mM ATPγS or 2 mM AMP-PNP. RNA was then
isolated and analyzed by denaturing PAGE on a 6M urea, 14% poly-
acrylamide gel, followed by autoradiography. Spliceosomal com-
plexes were analyzed by agarose gel electrophoresis in the presence
FIGURE 4. Electron microscopy of affinity-purified BATPγS complexes.
(A) Overview of negatively stained BATPγS complexes. (B) Gallery of class
averages of BATPγS complexes. (C) Typical class averages of B complexes
purified after 6 min of splicing in the presence of ATP (Wolf et al. 2009).
(D) Schematic representation of the human B complex, with main
structural features labeled.
ATPγS inhibits activation of the spliceosome
www.rnajournal.org 1335
 Cold Spring Harbor Laboratory Press on August 29, 2016 - Published by rnajournal.cshlp.orgDownloaded from 
of 0.65 µg/µL heparin (Das and Reed 1999) and bands were
visualized with a Typhoon phosphoimager (GE Healthcare).
MS2 affinity selection of splicing complexes
Spliceosomal complexes were isolated by MS2 affinity selection.
Briefly, MINX pre-mRNA containing three MS2 aptamers at its 3′
end was incubated with a 15-fold molar excess of MS2-MBP fusion
protein and then added to a splicing reaction lacking ATP but sup-
plemented with ATPγS. After incubating at 30°C for 180 min and
centrifuging to remove aggregates, the reaction was loaded onto a
MBP Trap HP column (GE Healthcare) after adding 100 mM
NaCl. The column was washed with G-150 buffer (20 mM
HEPES-KOH pH 7.9, 1.5 mMMgCl2, 150 mMNaCl) and complex-
es were eluted with G-150 buffer containing 1 mM maltose. Eluted
complexes were loaded onto a 14 mL linear 10%–30% (v/v) glycerol
gradient containing G-150 buffer, centrifuged at 25,000 rpm for 15
h at 4°C in a Sorvall TST 41.14 rotor and fractions were harvested
from the bottom. The distribution of 32P-labeled MINX RNA across
the gradient was determined by Cherenkov counting. Peak fractions
containing the spliceosomal complexes were pooled, and their RNA
and protein compositions determined by denaturing PAGE and 2D
gel electrophoresis, respectively.
2D gel electrophoresis and mass spectrometry
Two-dimensional gel electrophoresis of affinity-purified spliceoso-
mal complexes was performed as described in Agafonov et al.
(2011). For mass spectrometry, Coomassie-stained protein spots
were cut out of the 2D gel and proteins were digested in-gel with
trypsin and extracted. The extracted peptides were analyzed in a liq-
uid chromatography coupled electrospray ionization quadrupole
time of flight mass spectrometer (LTQOrbitrap XL) under standard
conditions. Proteins were identified by searching fragment spectra
against the NCBI nonredundant (nr) database using Mascot as a
search engine.
Electron microscopy
Purified spliceosomal complexes were loaded onto a 10%–30% (v/
v) glycerol gradient in buffer G150 containing a linear gradient of
0%–0.1% glutaraldehyde (GraFix method) (Kastner et al. 2008).
After centrifugation for 1:47 h at 60,000 rpm in a TH660 rotor,
the gradient was harvested from the bottom in 120 µL fractions.
Particles in peak gradient fractions were negatively stained with ura-
nyl formate by the single-carbon film method adopted from Golas
et al. (2003). Images were recorded using a CM 200-FEG electron
microscope (FEI) at a magnification of 115,000× with a 4k × 4k dig-
ital camera (TVIPS). After performance of a reference-free align-
ment procedure (Dube et al. 1993), images were subjected to
multivariate statistical analysis (MSA) and classification (van Heel
and Frank 1981; van Heel 1984; Dube et al. 1993). The resulting
class averages were used as reference images in subsequent rounds
of alignment until the class averages were stable.
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